person · Reporting owner
Mikan George Lawrence III
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AUTONATION, INC.AN · Entity 3730 | Director | January 02, 2026 | January 06, 2026 |
| ELLINGTON INCOME OPPORTUNITIES FUNDEIOM · Entity 112529 | Trustee | October 18, 2018 | November 01, 2018 |
| UNITEDHEALTH GROUP INCUNH · Entity 2809 | EVP UHG & CEO, Optum | June 05, 2011 | June 07, 2011 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AUTONATION, INC.
Report date January 02, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 22,170 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Grant · Acquired 1,210 · Balance 22,170 F1: 2026 grant of 1,210 vested restricted stock units (the "RSUs") pursuant to the AutoNation, Inc. 2024 Non-Employee Director Equity Plan (the "2024 Director Plan"). The RSUs will settle in shares of common stock, par value $0.01 per share, of AutoNation, Inc. (the "Company") in accordance with the terms of the award, including any deferral election made by the reporting person, and the 2024 Director Plan. Settlement of the RSUs will be accelerated in certain circumstances as provided in the terms of the award and the 2024 Director Plan, including in the event the reporting person ceases to serve as a non-employee director of the Company. |
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectBy Trust | 14,259 |
Reported balance
Holding disclosure · report date 2026-01-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 14,259 |
Filing footnotes · ownership attribution and instrument terms
F1: 2026 grant of 1,210 vested restricted stock units (the "RSUs") pursuant to the AutoNation, Inc. 2024 Non-Employee Director Equity Plan (the "2024 Director Plan"). The RSUs will settle in shares of common stock, par value $0.01 per share, of AutoNation, Inc. (the "Company") in accordance with the terms of the award, including any deferral election made by the reporting person, and the 2024 Director Plan. Settlement of the RSUs will be accelerated in certain circumstances as provided in the terms of the award and the 2024 Director Plan, including in the event the reporting person ceases to serve as a non-employee director of the Company.
ELLINGTON INCOME OPPORTUNITIES FUND
Report date October 18, 2018 · Filed November 01, 2018
This filing explicitly reported no securities owned.
UNITEDHEALTH GROUP INC
Report date June 05, 2011 · Filed June 07, 2011
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 209,278.777 |
Reported balance
After 2011-06-05 transaction · row 1
1 source rowRow 1 · 2011-06-05 · Tax withholding · Disposed 3,892 · Balance 209,278.777 |
| Common StockSEC Table I · non-derivative | Indirectby 401(k) | 142.9422 |
Reported balance
Holding disclosure · report date 2011-06-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 142.9422 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NeueHealth, Inc.
Report date October 02, 2025 · Filed October 06, 2025
Section 16 reporting ended · disclosed 2025-10-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-10-02 transaction · row 1
1 source rowRow 1 · 2025-10-02 · Disposition to issuer · Disposed 249,453 · Balance 0 F1: On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. F2: Pursuant to the Rollover Agreement, dated as of September 17, 2025 (the "Rollover Agreement"), entered into by and among NH Holdings 2025 SPV, L.P. ("Holdings"), NH Holdings 2025, Inc., NH Holdings Acquisition 2025, Inc. and the Reporting Person, the Reporting Person contributed its shares of Issuer common stock, Series A Convertible Perpetual Preferred Stock ("Series A Preferred Stock") and Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") to Holdings in exchange for Holdings common units, series A preferred units and series B preferred units on a one for one basis in accordance with the Rollover Agreement, and effective as of the effective time of the Merger (the "Effective Time"). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-10-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-10-02 · Disposition to issuer · Disposed 58,876 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1: On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. F5: Each Issuer restricted stock unit ("RSU") outstanding immediately prior to the Effective Time was assumed and adjusted into a restricted stock unit with respect to a number of shares of common stock of Parent equal to the number of shares of Issuer common stock subject to such Issuer RSU and continued to be subject to the same terms and restrictions set forth in the Issuer equity plans and any applicable individual award agreement issued thereunder (including with respect to vesting). F4: The original grant of these restricted stock units vest in equal annual installments beginning on 3/6/23. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-10-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-10-02 · Disposition to issuer · Disposed 260,000 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1: On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. F5: Each Issuer restricted stock unit ("RSU") outstanding immediately prior to the Effective Time was assumed and adjusted into a restricted stock unit with respect to a number of shares of common stock of Parent equal to the number of shares of Issuer common stock subject to such Issuer RSU and continued to be subject to the same terms and restrictions set forth in the Issuer equity plans and any applicable individual award agreement issued thereunder (including with respect to vesting). F6: The original grant of these restricted stock units vest in equal annual installments beginning on 3/11/24. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-10-02 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-10-02 · Disposition to issuer · Disposed 580,000 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1: On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. F5: Each Issuer restricted stock unit ("RSU") outstanding immediately prior to the Effective Time was assumed and adjusted into a restricted stock unit with respect to a number of shares of common stock of Parent equal to the number of shares of Issuer common stock subject to such Issuer RSU and continued to be subject to the same terms and restrictions set forth in the Issuer equity plans and any applicable individual award agreement issued thereunder (including with respect to vesting). F7: All of these restricted stock units vest on 10/11/26. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc.
F2: Pursuant to the Rollover Agreement, dated as of September 17, 2025 (the "Rollover Agreement"), entered into by and among NH Holdings 2025 SPV, L.P. ("Holdings"), NH Holdings 2025, Inc., NH Holdings Acquisition 2025, Inc. and the Reporting Person, the Reporting Person contributed its shares of Issuer common stock, Series A Convertible Perpetual Preferred Stock ("Series A Preferred Stock") and Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") to Holdings in exchange for Holdings common units, series A preferred units and series B preferred units on a one for one basis in accordance with the Rollover Agreement, and effective as of the effective time of the Merger (the "Effective Time").
F3: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F4: The original grant of these restricted stock units vest in equal annual installments beginning on 3/6/23.
F5: Each Issuer restricted stock unit ("RSU") outstanding immediately prior to the Effective Time was assumed and adjusted into a restricted stock unit with respect to a number of shares of common stock of Parent equal to the number of shares of Issuer common stock subject to such Issuer RSU and continued to be subject to the same terms and restrictions set forth in the Issuer equity plans and any applicable individual award agreement issued thereunder (including with respect to vesting).
F6: The original grant of these restricted stock units vest in equal annual installments beginning on 3/11/24.
F7: All of these restricted stock units vest on 10/11/26.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2009 Filed Jun 8, 2009 21:19 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 3,891 | $27.10 | $105,446.10 |
DisclosureSEC source: 0000731766-09-000060 · edgardoc.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,518 F1 · balance_after: Includes dividend shares received through UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| February 23, 2009 Filed Feb 26, 2009 02:45 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantStock Appreciation Rights · Derivative | 113,122 | $0.00 Strike: $29.74 | $0.00 |
DisclosureSEC source: 0000731766-09-000034 · edgardoc.xml · derivative · entry 3 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,122 Underlying: Common Stock · 113,122 shares Expires 2019-02-23 F3 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013. Read SEC document |
| February 23, 2009 Filed Feb 26, 2009 02:45 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 38,462 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-09-000034 · edgardoc.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,406 F1 · security: The restricted stock units will vest at a rate of 25% annually on February 3 from the years 2010 through 2013. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 23, 2009, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of average EPS growth percentanges and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 76,923. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| August 22, 2008 Filed Aug 27, 2008 01:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $18.13 | $0.00 |
DisclosureSEC source: 0001181431-08-050209 · rrd217069.xml · derivative · entry 10 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2012-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning 1/7/03. Read SEC document |
| August 22, 2008 Filed Aug 27, 2008 01:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $17.39 | $0.00 |
DisclosureSEC source: 0001181431-08-050209 · rrd217069.xml · derivative · entry 9 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires 2012-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning 1/7/03. Read SEC document |
| August 22, 2008 Filed Aug 27, 2008 01:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $16.63 | $0.00 |
DisclosureSEC source: 0001181431-08-050209 · rrd217069.xml · derivative · entry 8 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2011-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning 6/1/02. Read SEC document |
| August 22, 2008 Filed Aug 27, 2008 01:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $14.18 | $0.00 |
DisclosureSEC source: 0001181431-08-050209 · rrd217069.xml · derivative · entry 7 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2011-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning 6/1/02. Read SEC document |
| August 22, 2008 Filed Aug 27, 2008 01:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | SaleCommon Stock | 100,000 | $30.27 | $3,027,270.00 |
DisclosureSEC source: 0001181431-08-050209 · rrd217069.xml · nonDerivative · entry 5 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,944 F2 · price: This transaction was executed in multiple trades at prices ranging from $30.25 to $30.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| August 22, 2008 Filed Aug 27, 2008 01:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionCommon Stock | 25,000 | $18.13 | $453,137.50 |
DisclosureSEC source: 0001181431-08-050209 · rrd217069.xml · nonDerivative · entry 4 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| August 22, 2008 Filed Aug 27, 2008 01:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionCommon Stock | 35,000 | $17.39 | $608,562.50 |
DisclosureSEC source: 0001181431-08-050209 · rrd217069.xml · nonDerivative · entry 3 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| August 22, 2008 Filed Aug 27, 2008 01:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionCommon Stock | 10,000 | $16.63 | $166,250.00 |
DisclosureSEC source: 0001181431-08-050209 · rrd217069.xml · nonDerivative · entry 2 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| August 22, 2008 Filed Aug 27, 2008 01:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionCommon Stock | 30,000 | $14.18 | $425,250.00 |
DisclosureSEC source: 0001181431-08-050209 · rrd217069.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| June 05, 2008 Filed Jun 9, 2008 23:15 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantStock Appreciation Rights · Derivative | 203,642 | $0.00 Strike: $33.94 | $0.00 |
DisclosureSEC source: 0000731766-08-000096 · edgardoc.xml · derivative · entry 3 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,642 Underlying: Common Stock · 203,642 shares Expires 2018-06-05 F3 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on June 5 from the years 2009 through 2012. Read SEC document |
| June 05, 2008 Filed Jun 9, 2008 23:15 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 36,452 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-08-000096 · edgardoc.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,503 F1 · security: The restricted stock units will vest at a rate of 25% annually on June 5 from the years 2009 through 2012. F2 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| May 28, 2007 Filed May 31, 2007 01:27 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantStock Appreciation Rights · Derivative | 175,000 | $0.00 Strike: $54.41 | $0.00 |
DisclosureSEC source: 0001181431-07-036390 · rrd160920.xml · derivative · entry 2 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2017-05-28 F2 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on May 28 from the years 2008 through 2011. Read SEC document |
| May 28, 2007 Filed May 31, 2007 01:27 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantStock Appreciation Rights · Derivative | 75,000 | $0.00 Strike: $54.41 | $0.00 |
DisclosureSEC source: 0001181431-07-036390 · rrd160920.xml · derivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2017-05-28 F1 · derivative.exercise_date: The stock appreciation rights vest 100% on May 28, 2013. Read SEC document |
| April 18, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $18.12 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 4 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2012-01-07 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 18, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $17.39 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 3 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 50,000 shares Expires 2012-01-07 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 18, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | Not disclosed Strike: $16.63 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 2 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2011-06-01 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 18, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | Not disclosed Strike: $14.18 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 10,000 shares Expires 2011-06-01 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 45,000 | Not disclosed Strike: $60.07 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 18 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2015-10-31 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 45,000 | Not disclosed Strike: $57.89 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 17 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires 2015-10-31 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $48.57 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 16 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2015-05-02 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $47.34 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 15 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2015-05-02 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 190,000 | Not disclosed Strike: $42.87 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 14 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock · 190,000 shares Expires 2014-11-04 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 190,000 | Not disclosed Strike: $38.88 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 13 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 190,000 shares Expires 2014-11-04 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 150,000 | Not disclosed Strike: $30.71 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 12 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2014-05-10 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 150,000 | Not disclosed Strike: $30.17 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 11 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150,000 shares Expires 2014-05-10 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 52,500 | Not disclosed Strike: $28.10 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 10 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 52,500 shares Expires 2013-10-28 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 52,500 | Not disclosed Strike: $26.18 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 9 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 52,500 shares Expires 2013-10-28 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 75,000 | Not disclosed Strike: $20.73 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 8 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2013-02-12 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 75,000 | Not disclosed Strike: $20.06 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 7 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 75,000 shares Expires 2013-02-12 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 30,000 | Not disclosed Strike: $22.11 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 6 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2012-08-05 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 30,000 | Not disclosed Strike: $20.54 | Not disclosed |
DisclosureSEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 5 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2012-08-05 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.